Showing 25901 - 25910 of 27827 for "Pharmaceuticals and life sciences" with applied filters
17 June 2015 by Daniel Barros
Daniel Barros of Philippi Prietocarrizosa & Uría in Santiago looks at the issues surrounding concession terminations
17 June 2015 by Ferdinand Jullaga of Mochtar Karuwin Komar
Ferdinand Jullaga of Mochtar Karuwin Komar in Jakarta answers the key questions investors need to know about the Indonesian energy market
17 June 2015 by Ekenberg & Andersson
PRESS RELEASE, Stockholm, 17 June, 2015
01 June 2015 by Yuri Ide
Yuri Ide of Anderson Mori & Tomotsune assesses the bankruptcy and insolvency regime in Japan
01 June 2015 by Boris Frederiksen and Morten Plannthin
Boris Frederiksen and Morten Plannthin of Poul Schmith assess the bankruptcy and insolvency regime in Denmark
01 June 2015 by Giulia Battaglia and Antonio Tavella
Giulia Battaglia and Antonio Tavella of Chiomenti assess the bankruptcy and insolvency regime in Italy
01 June 2015 by François Cautaerts and Chan Park
François Cautaerts and Chan Park of Molitor assess the bankruptcy and insolvency regime in Luxembourg
01 June 2015 by William Day and Emily Hogan
William Day and Emily Hogan of Arthur Cox assess the bankruptcy and insolvency regime in Ireland
01 June 2015 by Peter Vrabel and Robert Vasko
Peter Vrabel and Robert Vasko of Legate assess the bankruptcy and insolvency regime in the Slovak Republic
01 June 2015 by Ben Mays and Sharon Mungall
Ben Mays and Sharon Mungall of Carey Olsen assess the bankruptcy and insolvency regime in the British Virgin Islands